Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience

PURPOSE: To explore the benefit yielded by radiotherapy (RT), we report a series of metastatic renal cell carcinoma (RCC) patients treated with concomitant RT plus Nivolumab. METHODS/PATIENTS: Patients undergoing Nivolumab treatment plus concomitant RT (ablative or palliative) were included. RT was...

Descripción completa

Detalles Bibliográficos
Autores principales: Francolini, Giulio, Campi, Riccardo, Di Cataldo, Vanessa, Detti, Beatrice, Loi, Mauro, Triggiani, Luca, La Mattina, Salvatore, Borghetti, Paolo, Magrini, Stefano Maria, Nicosia, Luca, Alongi, Filippo, Ghirardelli, Paolo, Vavassori, Vittorio, Allegra, Andrea Gaetano, Aquilano, Michele, Scoccimarro, Erika, Peruzzi, Anna, Pastina, Pierpaolo, Visani, Luca, Desideri, Isacco, Serni, Sergio, Meattini, Icro, Livi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Brief Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418086/
https://www.ncbi.nlm.nih.gov/pubmed/35739349
http://dx.doi.org/10.1007/s12094-022-02844-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418086/
https://www.ncbi.nlm.nih.gov/pubmed/35739349
http://dx.doi.org/10.1007/s12094-022-02844-5

Ejemplares similares